CCNE1 and Parkinson disease: The results of the Wilcoxon rank‐sum test revealed significant downregulation of the CCNE1 gene expression in PD patients (p < 0.05) (Figure 1a–c), which is consistent with the negative causal effect (β < 0) observed in the MR analysis (Table S1).